Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-03-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-024-01029-3 |